Design Therapeutics Inc. Common Stock (DSGN)

About DSGN

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.designtx.com/

Fundamentals

Market cap

$861.75M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.18

Dividend yield

—

Beta

1.66

Avg. volume

—

Design Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• DSGN

  Design Therapeutics Inc. Common Stock

  $15.12

  ▼ 0.85%
  Market cap $861.75MP/E —
  $5.04$17.25
• ACRS

  Aclaris Therapeutics Inc. Common Stock

  $6.01

  ▼ 2.44%
  Market cap $850.55MP/E —
  $1.74$6.6
• AMPH

  Amphastar Pharmaceuticals Inc. Common Stock

  $22.01

  ▲ 0.59%
  Market cap $873.48MP/E 10.93
  $16.65$31.26
• ABUS

  Arbutus Biopharma Corporation Common Stock

  $5.07

  ▼ 1.93%
  Market cap $896.82MP/E 5.61
  $3.5$5.45
• ANNX

  Annexon Inc. Common Stock

  $4.97

  ▼ 5.33%
  Market cap $917.52MP/E —
  $2.03$7.18
• MNPR

  Monopar Therapeutics Inc. Common Stock

  $112.17

  ▼ 1.55%
  Market cap $805.29MP/E —
  $32.77$124.82
• CLYM

  Climb Bio Inc. Common Stock

  $14.56

  ▼ 3.32%
  Market cap $801.68MP/E —
  $1.54$18.33

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Marvell Technology, PayPal, Rubrik And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
  Benzinga · 8/28/2026
• Design Therapeutics Q2 EPS $(0.32) Beats $(0.34) Estimate
  Benzinga · 8/3/2026

• Gover Justin D. · June 9, 2026 · Grant

  30.0K
• Berger Heather A. · June 9, 2026 · Grant

  30.0K
• George Simeon · June 9, 2026 · Grant

  30.0K
• LAPPE RODNEY W · June 9, 2026 · Grant

  30.0K
• Shapiro David · June 9, 2026 · Grant

  30.0K
• John P. Schmid · June 9, 2026 · Grant

  30.0K
• Shapiro David · March 31, 2026 · Grant

  7.5K
• Shapiro David · March 31, 2026 · Grant

  60.0K

Institutional Ownership

March 31, 2026

Total shares held

37.63M

Total value held

$391.38M

Institutional holders

121